Gossamer Bio regains Nasdaq minimum bid price compliance; listing matter closed

Gossamer Bio, Inc.

Received Nasdaq letter on July 18, 2024 confirming regained compliance with minimum bid price rule.
Previous non-compliance notice dated May 22, 2024; stock had failed to maintain $1.00 minimum bid for 30 consecutive days.
The minimum bid price deficiency is now resolved; Nasdaq has closed the matter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.